MDXG Q2 2025 Earnings — MiMedx Group, Inc. Revenue & Financial Results | Market Cap Arena

MDXGMiMedx Group, Inc.

$684M

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$99M+13.1% YoY

Gross Profit

$80M81.1% margin

Operating Income

$12M12.5% margin

Net Income

$10M9.8% margin

EPS (Diluted)

$0.06

QoQ Revenue Growth

+11.8%

Cash Flow

Operating Cash Flow

$14M

Free Cash Flow

$14M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$291M

Total Liabilities

$74M

Stockholders' Equity

$217M

Cash & Equivalents

$119M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$99M	$87M	+13.1%
Gross Profit	$80M	$72M	+10.8%
Operating Income	$12M	$23M	-47.2%
Net Income	$10M	$18M	-45.4%

Revenue Segments

Surgical

$34M100%